Gemcitabine 38 mg/mL

Gemcitabine 38 mg/mL is an injectable solution used for various medical treatments. This single-dose vial is manufactured by Hospira, Inc. in the USA, and is administered intravenously.

Gemcitabine is commonly used in cancer treatments, particularly for certain types of solid tumors. It works by interfering with the growth and spread of cancer cells. The specific uses of Gemcitabine 38 mg/mL may vary depending on the type and stage of cancer being treated.

Common effects of Gemcitabine may include fatigue, nausea, and a decrease in blood cell counts. Some individuals may also experience hair loss or changes in appetite. These effects can vary widely among patients.

Gemcitabine should be handled with care, as it is a potent medication. It is important to follow the instructions provided by healthcare professionals regarding its administration. Proper disposal of used vials is crucial to avoid contamination.

Gemcitabine may interact with other medications, including those that suppress the immune system or affect blood cell production. It is important to inform healthcare providers about all medications being taken to avoid potential interactions.